An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals

Clinical and Experimental Hypertension

Volumn 21, Issue 5-6, 1999, Pages 517-529

  Neal, B ^a   MacMahon, S ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Angiotensin converting enzyme inhibitors; Beta blockers; Calcium antagonists; Coronary heart disease; Diuretics; Meta analysis; Overview; Randomized trials; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESEARCH; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME;

EID: 0032802074     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909060985     Document Type: Conference Paper

References (24)

1. Collins R, Peto R, MacMahon S, Herbert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-39.
2. MacMahon S, Rodgers A. The effects of antihypertensive treatment on vascular disease: reappraisal of the evidence in 1993. J Vasc Med Biol 1994;4:265-71.
3. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994;50:272-298.
4. Gueyffier F, Boutitie F, Boissel JP. INDANA: a meta-analysis on individual patient data in hypertension. Protocol and preliminary results. Therapie 1995;50:353-362.
5. Kostis J, Davis B, Cutler J, Grimm R, Berge K, Cohen J, Lacy C, Perry H, Blaufox M, Wassertheil-Smoller S, Black H, Schron E, Berkson D, Curb J, Smith W, McDonald R, Applegate W. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension (ISH). SHEP Cooperative Research Group. JAMA 1997;278:212-6.
6. Yusuf S, Thomas T, Abbott RD. Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension 1989;13:74-9.
7. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-371.
8. Doughty RN, Rodgers A, Sharpe N, MacMahon S. Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomised controlled trials. Eur Heart J 1997;18:560-565.
9. Hansson L, Lindholm L, Niskanen L, Lanke J, Hedner T, Niklason A, Luomannmaki K, Dahlof B, de Faire U, Morlin C, Karlberg B, Wester P, Bjorck J-E, for the CAPPP Study Group. Principal results of the captopril prevention project (CAPPP). Lancet 1998;In press.
10. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. Br Med J 1998;317:713-720.
11. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450-1456.
12. Lonn EM, Yusuf S, Jha P, Montague TJ, Teo KK, Benedict CR, Pitt B. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994;90:2056-2067.
13. Staessen J, Fagard R, Thijs L, Celis H, Arabidze G, Birkenhager W, Bulpitt C, de Leeuw P, Dollery C, Fletcher A, Forette F, Leonetti G, Nachev C, O'Brien E, Rosenfeld J, Rodicio J, Tuomilehto J, Zanchetti A, for the SYST-EUR Study Group. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-764.
14. Liu L, Wang J, Gong L, Liu G, Staessen J, for the Systolic Hypertension in China (SYST-CHINA) Collaborative Group. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J Hypertens 1998;In press.
15. Gong L, Zhang W, Zhu Y, Zhu J, 11 collaborating centres in the Shanghai area, Kong D, Page V, Ghadirian P, LeLorier J, Hamet P. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996;14:1237-1245.
16. Held P, Yusuf S, Furberg C. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J 1989:229:1187-1192.
17. Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the Second Danish Verapamil Trial (DAVIT-II) and other recent studies. Am J Cardiol 1991;67:1295-1297.
18. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. J Hypertens 1997;15:105-115.
19. Cohn J, Ziesche S, Loss L, Anderson G, and the V-HeFT Study Group. Effect of felodipine on short-term exercise and neurohormone and long-term mortality in heart failure: results of V-Heft III. Circulation 1995;92:1-143.
20. Packer M, O'Connor C, Ghali J, Pressler M, Carson P, Belkin R, Miller A, Neuberg G, Frid D, Wertheimer J, Cropp A, DeMets D, for the Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996;335:1107-1114.
21. Hansson L, Zanchetti A, Carruthers S, Dahlof B, Elmfeldt D, Menard J, Julius S, Rahn K, Wedel H, Westerling S, for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. Lancet 1998;351:1755-1762.
22. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. Br Med J 1998;317:703-713.
23. Collins R, Gray R, Godwin J, Peto R. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Stat Med 1987;6:245-250.
24. World Health Organisation-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure lowering treatments. Journal of Hypertension 1998;16:127-137.